SCHEMBL16257575

SCHEMBL16257575

CCOC(=O)c1ncnc(Nc2cc(OC)c3ccccc3c2)c1C

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
RAB9A P51151 1/20 0.47
SHMT2 P34897 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDR P35968 3/20 0.45
CDC25B P30305 4/20 0.45
EGFR P00533 1/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ANO1 Q5XXA6 1/20 0.44
ANO2 Q9NQ90 1/20 0.44
TP53 P04637 1/20 0.44
CDC25A P30304 1/20 0.43
CDC25C P30307 1/20 0.43
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257576 0.87 ANO1 (0.49) KDREGFRABCG2ANO1ANO2
SCHEMBL16257511 0.84 DHODH (0.55) MAPTSMN1; SMN2LMNAPOLBRAB9A
SCHEMBL16257591 0.80 EGFR (0.50) MAPTSMN1; SMN2LMNAPOLBRAB9A
SCHEMBL16257512 0.78 EGFR (0.48) MAPTSMN1; SMN2LMNAPOLBSHMT2
SCHEMBL16257608 0.75 HPGD (0.47) MAPTSMN1; SMN2LMNAPOLBRAB9A
SCHEMBL14318457 0.72 TP53 (0.65) MAPTSMN1; SMN2LMNAPOLBMEN1
SCHEMBL12179967 0.69 DHODH (0.52) LMNAKDRTP53
SCHEMBL16257589 0.68 CSNK2A2 (0.48) MAPTSMN1; SMN2LMNAPOLBRAB9A
SCHEMBL16505479 0.67 KDM4E (0.56) MAPTSMN1; SMN2POLBMEN1KMT2A
SCHEMBL6662871 0.67 KDR (0.77) RAB9AKDREGFRKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed